Direct-acting Antiviral Agents for the Treatment of Chronic Hepatitis C Virus Infection
Tatsuo Kanda, Shingo Nakamoto, Masato Nakamura, Xia Jiang, Tatsuo Miyamura, Shuang Wu, Osamu Yokosuka
doi:10.14218/JCTH.2013.00025
A Review of the Challenges Associated with the Diagnosis and Therapy of Primary Sclerosing Cholangitis
Mohammed Saadi, Christine Yu, Mohamed O. Othman
[ Html ]
[ PDF ] 45-52
doi:10.14218/JCTH.2013.00021
Emerging Role of Interleukin 22 in Hepatitis B Virus Infection: a Double‐edged Sword
Wei Gao, Yu-Chen Fan, Ji-Yuan Zhang, Ming-Hua Zheng
[ Html ]
[ PDF ] 103-108
doi:10.14218/JCTH.2013.00013
Autoimmune Hepatitis: Clinical Review with Insights into the Purinergic Mechanism of Disease
Nikhil Kapila, Jennifer T. Higa, Maria Serena Longhi, Simon C. Robson
[ Html ]
[ PDF ] 79-86
doi:10.14218/JCTH.2013.00015
Diagnosis of Liver Involvement in Primary Sjögren Syndrome
Pilar Brito Zeron, Soledad Retamozo, Albert Bové, Belchin Adriyanov Kostov, Antoni Sisó, Manuel Ramos-Casals
[ Html ]
[ PDF ] 94-102
doi:10.14218/JCTH.2013.00011
Peginterferon Lambda‐1a, a New Therapeutic for Hepatitis C Infection, from Bench to Clinic
Henrik Andersen, Jeff Meyer, Jeremy Freeman, Sean E. Doyle, Kevin Klucher, Dennis M. Miller, Diana Hausman, Jan L. Hillson
[ Html ]
[ PDF ] 116-124
doi:10.14218/JCTH.2013.00014
The Role of MicroRNA in Hepatitis C Virus Replication
Xiao-Qiong Duan, Shi-Lin Li, Yu-Jia Li, Bing Liu, Pei-Bing Zeng, Chun-Hui Yang, Li-Min Chen
[ Html ]
[ PDF ] 125-130
doi:10.14218/JCTH.2013.00012
Hepatocellular Carcinoma in Non‐alcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, and Prevention
György Baffy
[ Html ]
[ PDF ] 131-137
doi:10.14218/JCTH.2013.00005